Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (2) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (6) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Poncette, Lucia (1) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (9) Willimsky, Gerald Dr. (5) (-) Blankenstein, Thomas Prof. Dr. (28) (-) Rhein, Simone Dr. (1) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (18) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (28) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) Translationale Onkologie solider Tumore (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) (-) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 28 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Rhein, Simone Dr.Molekulare Immunologie und Gentherapie 20032008201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2003 / Verh Dtsch Ges Pathol Die Ueberexpression von NPM-ALK in haematopoietischen Stammzellen induziert verschiedene maligne Non-Hodgkin-Lymphome in der IL-9 transgenen Maus [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice] H. Merz K. Lange R. Nadrowitz W. Uckert T. Blankenstein A.C. Feller 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo 08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. Januar 2003 / Canc Res A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8T cells Z.H. Qin J. Schwartzkopff F. Pradera T. Kammertoens B. Seliger H. Pircher T. Blankenstein 10. August 2003 / Hum Gene Ther Retroviral vectors for high-level transgene expression in T lymphocytes B. Engels H. Cam T. Schueler S. Indraccolo M. Gladow C. Baum T. Blankenstein W. Uckert Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Januar 2003 / Verh Dtsch Ges Pathol Die Ueberexpression von NPM-ALK in haematopoietischen Stammzellen induziert verschiedene maligne Non-Hodgkin-Lymphome in der IL-9 transgenen Maus [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice] H. Merz K. Lange R. Nadrowitz W. Uckert T. Blankenstein A.C. Feller
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo
08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. Januar 2003 / Canc Res A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8T cells Z.H. Qin J. Schwartzkopff F. Pradera T. Kammertoens B. Seliger H. Pircher T. Blankenstein
10. August 2003 / Hum Gene Ther Retroviral vectors for high-level transgene expression in T lymphocytes B. Engels H. Cam T. Schueler S. Indraccolo M. Gladow C. Baum T. Blankenstein W. Uckert